Comments
Commented by Armin Schulz on November 21st, 2024 | 07:30 CET
Barrick Gold, Globex Mining, Coinbase – When the rockets fly: Your anti-crisis investment
In today's interconnected world, geopolitical tensions not only dominate headlines but also have a direct impact on financial markets and investment decisions. In the face of recent escalations in the Middle East and Ukraine, the search for safe investments is more important than ever. While gold continues to shine as a proven hedge, commodities and cryptocurrencies are also gaining investors' attention. In the case of commodities, Western countries are heavily dependent on China and Russia. Since Donald Trump's election victory in the US, cryptocurrencies have gone through the roof. These investment options not only offer protection but also opportunities for significant profits. We look at a company from each sector.
Read
Commented by Juliane Zielonka on November 21st, 2024 | 07:15 CET
Bayer, BioNxt Solutions, BioNTech – Patents and acquisitions for market penetration
Three companies in the pharmaceutical industry are pursuing different strategies to strengthen their market position: Bayer is making targeted investments in the Japanese heart medication market and acquiring the rights to a promising active ingredient for treating heart muscle diseases for up to EUR 560 million. BioNxt Solutions is developing an innovative form of medication delivery for drugs to treat the incurable disease of multiple sclerosis - with an absolute focus on patients. The biotech company is thus securing patent protection in key international markets. BioNTech, in turn, is massively expanding into the Asian oncology market with the USD 800 million acquisition of the Chinese company Biotheus. All three companies are expanding their positions in lucrative future markets. Which strategy will be successful?
Read
Commented by André Will-Laudien on November 21st, 2024 | 07:00 CET
Make Trump love hydrogen – why not? Nel, Plug Power, First Hydrogen, thyssenkrupp and nucera
- Even though Trump ignores or denies climate change, he has an advisory team focused on the future of the US. After all, the Republican Party wants to continue to govern even after the Donald era. However, the current election result is weighing on the entire green tech sector, so investors should selectively take advantage of the current sell-off. After all, the technologies will not disappear but continue to develop in the background. Hydrogen propulsion systems still play a niche role but could become more important due to technological advances and infrastructure investments. Their future depends heavily on how effectively renewable hydrogen can be produced and made available and how costs develop compared to other zero-emission technologies. First Hydrogen is demonstrating how the logistics and transportation sector could develop under the EU's "Net Zero 2050" target! Sentiment is low, so investors should switch in time to benefit from the impending rebound.
Commented by André Will-Laudien on November 20th, 2024 | 08:25 CET
Missiles for Russia! Returns lurk at thyssenkrupp, Rheinmetall, Almonty, Renk and Hensoldt?
Western missiles for Russia! A new escalation in the Ukraine conflict hits the trading floors of the stock markets, leading to significant losses for the DAX - dropping 400 points in just 24 hours. Portfolios now have to be quickly restructured as armaments are back in demand again. In addition, critical metals are also gaining traction because special elements such as tungsten are also needed to harden ammunition and military equipment. Those who pivot their portfolios swiftly could benefit from rapid revaluations.
Read
Commented by Fabian Lorenz on November 20th, 2024 | 08:15 CET
Takeover battle and soaring profits! Evotec, Bayer, Saturn Oil + Gas
A bombshell announcement came from Evotec late last week. US biotech company Halozyme Therapeutics is offering EUR 11 per Evotec share. Evotec was not informed in advance and seems to be preparing to fend off the takeover. Analysts believe the share price has moved far away from its fundamental value. So, should investors sell the stock now? Experts suggest investors should buy shares of Saturn Oil & Gas. The mid-sized oil producer from Canada is expected to be among the winners under the upcoming Trump administration and will likely soon be paying an attractive dividend. The stock has clear catch-up potential. Meanwhile, analysts are significantly reducing the target price for Bayer. Is there a chance of a turnaround at the agricultural and pharmaceutical giant?
Read
Commented by Armin Schulz on November 20th, 2024 | 07:00 CET
Evotec, Nyxoah, Bayer – A lot of excitement in the healthcare industry
The healthcare sector is currently abuzz with activity. Evotec is the focus of a potential takeover by the US company Halozyme, which has caused the shares of the German biotech company to skyrocket. At the same time, the Belgian medical technology company Nyxoah expects to receive FDA approval soon for its Genio system for the treatment of sleep apnea, which would pave the way for its market entry in the US. Bayer, on the other hand, disappointed with its latest quarterly figures, which showed a significant decline in revenue and EBITDA, leading to a slide in its share price. We take a closer look at these three companies.
Read
Commented by Fabian Lorenz on November 19th, 2024 | 07:15 CET
BUYING OPPORTUNITY in gold and billion-dollar investment: Barrick Gold, Thunder Gold, BYD
The price of gold is consolidating, the major gold producers are weakening and they could soon be forced into takeovers. This presents investors with an interesting buying opportunity with promising gold explorers. One of these takeover candidates is Thunder Gold. The Company has a highly promising project in Canada with excellent infrastructure and outstanding resources, which could soon increase further. Then a big player like Barrick Gold could strike. The second-largest gold producer has missed analyst estimates and could keep investors interested through acquisitions. The mood of German automakers is unlikely to improve when they look at BYD. The Chinese are currently celebrating a milestone and announcing a billion-dollar investment program for the integration of artificial intelligence. Should one take advantage of the buying opportunity now?
Read
Commented by André Will-Laudien on November 19th, 2024 | 07:10 CET
Energy-guzzling artificial intelligence – Uranium in focus! Higher prices possible for Palantir, F3 Uranium, SAP and SMCI!
The energy demand is skyrocketing! Currently, high-tech companies from Silicon Valley are investing in power generators and uranium companies. This is because they will all need many times more electricity in the coming years than they do today in order to roll out their AI-driven business models. Artificial intelligence consumes, on average, 10 to 15 times more energy than conventional search engine queries. As a result, industry leaders are no longer willing to leave future energy supplies solely in the hands of governments, as the risk of supply disruptions appears too great. For several months, nuclear companies in the US have been developing so-called small modular reactors, while the EU wants to continue with renewable energies. Investors should weigh these options carefully, as these trends present significant opportunities for growth.
Read
Commented by Armin Schulz on November 19th, 2024 | 07:05 CET
Nel ASA, dynaCERT, Daimler Truck – Decarbonization in focus
Nel ASA, dynaCERT and Daimler Truck are three companies involved in various areas of hydrogen technology, thus contributing to decarbonization. Nel ASA is a pioneer in the production of electrolysers that generate hydrogen from renewable energies. dynaCERT develops innovative systems that integrate hydrogen into combustion engines to reduce emissions. Daimler Truck is committed to hydrogen fuel cells for long-distance transportation and has achieved impressive ranges with the GenH2 Truck. Together, they are driving the use of hydrogen as a clean energy carrier and shaping the future of mobility and energy supply.
Read
Commented by Stefan Feulner on November 19th, 2024 | 07:00 CET
Novo Nordisk, BioNxt Solutions, Bavarian Nordic – Opportunities after a horror week
The past trading week was one to forget for the biotech and medtech sectors. With the nomination of the anti-vaccine Robert F. Kennedy as the future US Secretary of Health, stocks such as Moderna, Pfizer and BioNTech lost disproportionately. Even the broadly diversified Nasdaq Biotech Index closed with a weekly loss of over 10%. However, many analysts see the sudden slide as an attractive entry opportunity.
Read